Geert Harms

2.1k total citations · 1 hit paper
25 papers, 1.6k citations indexed

About

Geert Harms is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Geert Harms has authored 25 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Pathology and Forensic Medicine and 8 papers in Immunology. Recurrent topics in Geert Harms's work include Lymphoma Diagnosis and Treatment (8 papers), Cancer-related molecular mechanisms research (6 papers) and Galectins and Cancer Biology (4 papers). Geert Harms is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Cancer-related molecular mechanisms research (6 papers) and Galectins and Cancer Biology (4 papers). Geert Harms collaborates with scholars based in Netherlands, Germany and United States. Geert Harms's co-authors include Anke van den Berg, Sibrand Poppema, Tjasso Blokzijl, Bart‐Jan Kroesen, Debora de Jong, Joost Kluiver, S. Jacobs, Lydia Visser, Machiel J. Hardonk and Tineke van der Sluis and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and American Journal Of Pathology.

In The Last Decade

Geert Harms

24 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas

2005 548 citations Joost Kluiver, Sibrand Poppema et al. The Journal of Pathology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Geert Harms Netherlands	19	1.0k	846	358	221	216	25	1.6k
António Torres Spain	26	1.4k 1.4×	530 0.6×	252 0.7×	80 0.4×	255 1.2×	48	2.0k
Zongdong Li United States	14	1.2k 1.1×	987 1.2×	473 1.3×	199 0.9×	168 0.8×	26	1.9k
Pia Ragno Italy	26	761 0.7×	937 1.1×	312 0.9×	82 0.4×	448 2.1×	53	1.8k
Kathryn A. Holthaus United States	8	576 0.6×	348 0.4×	137 0.4×	41 0.2×	160 0.7×	9	1.1k
Zhenke Wen China	25	718 0.7×	415 0.5×	1.1k 3.1×	51 0.2×	272 1.3×	62	1.9k
Yasushi Saga Japan	22	670 0.6×	251 0.3×	200 0.6×	86 0.4×	354 1.6×	66	1.4k
Adrian A. Lobito United States	13	925 0.9×	158 0.2×	876 2.4×	95 0.4×	177 0.8×	16	1.4k
Simone Anfossi United States	20	854 0.8×	845 1.0×	316 0.9×	68 0.3×	648 3.0×	34	1.8k
Laura V. Doyle United States	17	500 0.5×	272 0.3×	748 2.1×	71 0.3×	393 1.8×	27	1.5k
Svetlana Shulga‐Morskaya United States	10	835 0.8×	399 0.5×	1.0k 2.9×	58 0.3×	128 0.6×	10	2.1k

Countries citing papers authored by Geert Harms

Since Specialization

Citations

This map shows the geographic impact of Geert Harms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geert Harms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geert Harms more than expected).

Fields of papers citing papers by Geert Harms

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geert Harms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geert Harms. The network helps show where Geert Harms may publish in the future.

Co-authorship network of co-authors of Geert Harms

This figure shows the co-authorship network connecting the top 25 collaborators of Geert Harms. A scholar is included among the top collaborators of Geert Harms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geert Harms. Geert Harms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pasch, Andreas, Martin Feelisch, Femke Waanders, et al.. (2019). Serum free thiols in type 2 diabetes mellitus: A prospective study. Journal of Clinical & Translational Endocrinology. 16. 100182–100182. 23 indexed citations

Mencke, Rik, Anja T. Umbach, Jakob Voelkl, et al.. (2019). Klotho Deficiency Induces Arteriolar Hyalinosis in a Trade-Off with Vascular Calcification. American Journal Of Pathology. 189(12). 2503–2515. 9 indexed citations

Mencke, Rik, Geert Harms, Jill Moser, et al.. (2017). Human alternative Klotho mRNA is a nonsense-mediated mRNA decay target inefficiently spliced in renal disease. JCI Insight. 2(20). 53 indexed citations

Mencke, Rik, Geert Harms, Martin H. de Borst, et al.. (2015). Membrane-bound Klotho is not expressed endogenously in healthy or uraemic human vascular tissue. Cardiovascular Research. 108(2). 220–231. 33 indexed citations

Gibcus, Johan H., Geert Harms, Debora de Jong, et al.. (2009). Hodgkin Lymphoma Cell Lines Are Characterized by a Specific miRNA Expression Profile. Neoplasia. 11(2). 167–IN9. 117 indexed citations

Bart, Joost, Inge Platteel, Tineke van der Sluis, et al.. (2009). Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma. BMC Cancer. 9(1). 163–163. 180 indexed citations

Robertus, Jan‐Lukas, Geert Harms, Tjasso Blokzijl, et al.. (2009). Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma. Modern Pathology. 22(4). 547–555. 62 indexed citations

Wang, Miao, Jan‐Lukas Robertus, Johan H. Gibcus, et al.. (2009). miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes. Laboratory Investigation. 89(6). 708–716. 86 indexed citations

Ma, Yue, Lydia Visser, Tjasso Blokzijl, et al.. (2008). The CD4+CD26− T-cell population in classical Hodgkin's lymphoma displays a distinctive regulatory T-cell profile. Laboratory Investigation. 88(5). 482–490. 45 indexed citations

10.

Kok, Klaas, Joost Kluiver, Eva van den Berg, et al.. (2006). BCL6 alternative breakpoint region break and homozygous deletion of 17q24 in the nodular lymphocyte predominance type of Hodgkin's lymphoma–derived cell line DEV. Human Pathology. 37(6). 675–683. 24 indexed citations

11.

Berg, Anke van den, Geert Harms, Hans Vos, et al.. (2006). Strongly enhanced IL-10 production using stable galectin-1 homodimers. Molecular Immunology. 44(4). 506–513. 85 indexed citations

12.

Kluiver, Joost, Klaas Kok, Ines Pfeil, et al.. (2006). Global correlation of genome and transcriptome changes in classical Hodgkin lymphoma. Hematological Oncology. 25(1). 21–29. 19 indexed citations

13.

Poppema, Sibrand, et al.. (2005). Expression of the T-Cell Transcription Factors, GATA-3 and T-bet, in the Neoplastic Cells of Hodgkin Lymphomas. American Journal Of Pathology. 166(1). 127–134. 48 indexed citations

14.

Kluiver, Joost, Sibrand Poppema, Debora de Jong, et al.. (2005). BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. The Journal of Pathology. 207(2). 243–249. 548 indexed citations breakdown →

15.

Blokzijl, Tjasso, Geert Harms, Megan S. Lim, et al.. (2005). TIMP‐1 expression in anaplastic large cell lymphoma is usually restricted to macrophages and only seldom observed in tumour cells. The Journal of Pathology. 206(4). 445–450. 6 indexed citations

16.

Berg, Anke van den, Tjasso Blokzijl, Geert Harms, et al.. (2004). Dimeric galectin‐1 induces IL‐10 production in T‐lymphocytes: an important tool in the regulation of the immune response. The Journal of Pathology. 204(5). 511–518. 78 indexed citations

17.

Jansen, Robert W., Peter Olinga, Geert Harms, & Dirk K. F. Meijer. (1993). Pharmacokinetic Analysis and Cellular Distribution of the Anti-HIV Compound Succinylated Human Serum Albumin (Suc-HSA) in Vivo and in the Isolated Perfused Rat Liver. Pharmaceutical Research. 10(11). 1611–1614. 31 indexed citations

18.

Jansen, Robert W., Grietje Molema, Geert Harms, et al.. (1991). Formaldehyde treated albumin contains monomeric and polymeric forms that are differently cleared by endothelial and kupffer cells of the liver: Evidence for scavenger receptor heterogeneity. Biochemical and Biophysical Research Communications. 180(1). 23–32. 46 indexed citations

19.

Harms, Geert, Christine D. Dijkstra, & Machiel J. Hardonk. (1990). Glycosyl receptors in macrophage subpopulations of rat spleen and lymph node. Cell and Tissue Research. 262(1). 35–40. 37 indexed citations

20.

Harms, Geert, Harry van Goor, J Koudstaal, Lisa Ley, & Mj Hardonk. (1988). Double immunohistochemical demonstration of antigen expression and DNA-incorporated 5-bromodeoxyuridine in frozen and plastic embedded sections.. PubMed. 36. 353–9. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact